Earnings Call · Q2 FY2025·2025-08-04

Q2 25EPS +6.35%·Rev n/aQ1 25EPS -5.36%·Rev n/aQ4 24EPS -1.00%·Rev n/aQ3 24EPS +6.05%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Susie Lisa — Senior Vice President, Investor Relations

Reshma Kewalramani — Chief Executive Officer and President

Duncan McKechnie — Executive Vice President, Chief Commercial Officer

Charles F. Wagner — Chief Financial Officer

−20.6%1d on move date−20.1% vs SPY3d−20.5%5d−20.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access